The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Structure−Function Relationships in Aminoquinolines: Effect of Amino and Chloro Groups on Quinoline−Hematin Complex Formation, Inhibition of β-Hematin Formation, and Antiplasmodial Activity
Abstract
Comparison of 19 aminoquinolines supports the hypothesis that chloroquine and related antimalarials act by complexing ferriprotoporphyrin IX (Fe(III)PPIX), inhibiting its conversion to beta-hematin (hemozoin) and hence its detoxification. The study suggests that a basic amino side chain is also essential for antiplasmodial activity. 2- And 4-aminoquinolines are unique in their strong affinity for Fe(III)PPIX, and attachment of side chains to the amino group has relatively little influence on the strength of complex formation. Association with Fe(III)PPIX is necessary, but not sufficient, for inhibiting beta-hematin formation. Presence of a 7-chloro group in the 4-aminoquinoline ring is a requirement for beta-hematin inhibitory activity, and this is also unaffected by side chains attached to the amino group. In turn, beta-hematin inhibitory activity is necessary, but not sufficient, for antiplasmodial activity as the presence of an aminoalkyl group attached to the 4-amino-7-chloroquinoline template is essential for strong activity. We thus propose that the 4-aminoquinoline nucleus of chloroquine and related antimalarials is responsible for complexing Fe(III)PPIX, the 7-chloro group is required for inhibition of beta-hematin formation, and the basic amino side chain is required for drug accumulation in the food vacuole of the parasite.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Human Malaria Parasites in Continuous Culture
Trager, W., & Jensen, J. B. (1976) · Science · doi:10.1126/science.781840 · Cited by 7,844
Lysosomes, pH and the Anti-malarial Action of Chloroquine
HOMEWOOD, C. A., WARHURST, D. C., PETERS, W., & BAGGALEY, V. C. (1972) · Nature · doi:10.1038/235050a0 · Cited by 530
Banding in Human Chromosomes treated with Trypsin
WANG, H. C., & FEDOROFF, S. (1972) · Nature New Biology · doi:10.1038/newbio235052a0 · Cited by 514
Plasmodium Hemozoin Formation Mediated by Histidine-Rich Proteins
Sullivan, D. J., Gluzman, I. Y., & Goldberg, D. E. (1996) · Science · doi:10.1126/science.271.5246.219 · Cited by 436
Malarial haemozoin/β-haematin supports haem polymerization in the absence of protein
Dorn, A., Stoffel, R., Matile, H., Bubendorf, A., & Ridley, R. G. (1995) · Nature · doi:10.1038/374269a0 · Cited by 389
Pettigrew, J. D., & Konishi, M. (1976) · Science · doi:10.1126/science.948741 · Cited by 312
Ginsburg, H., Famin, O., Zhang, J., & Krugliak, M. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00184-1 · Cited by 287
Heme Degradation in the Presence of Glutathione
Atamna, H., & Ginsburg, H. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.42.24876 · Cited by 216
Hawley, S. R., Bray, P. G., Mungthin, M., Atkinson, J. D., O’Neill, P. M., & Ward, S. A. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.3.682 · Cited by 213
Bohle, D. S., Dinnebier, R. E., Madsen, S. K., & Stephens, P. W. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.2.713 · Cited by 166
Xanthones as antimalarial agents; studies of a possible mode of action
Ignatushchenko, M., Winter, R. W., Bächinger, H. P., Hinrichs, D. J., & Riscoe, M. K. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00405-5 · Cited by 154
Inhibition of DNA and RNA polymerase reactions by chloroquine.
Cohen, S. N., & Yielding, K. L. (1965) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.54.2.521 · Cited by 118
Synthesis, Antimalarial Activity, and Molecular Modeling of Tebuquine Analogues
O’Neill, P. M., Willock, D. J., Hawley, S. R., Bray, P. G., Storr, R. C., Ward, S. A., & Park, B. K. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm960370r · Cited by 110
Peptidases from Plasmodium falciparum cultured in vitro
Gyang, F. N., Poole, B., & Trager, W. F. (1982) · Molecular and Biochemical Parasitology · doi:10.1016/0166-6851(82)90034-2 · Cited by 78
Studies on haemin in dimethyl sulphoxide/water mixtures
Collier, G., Pratt, J. M., Wet, C. R. D., & TSHABALALA, C. F. (1979) · Biochemical Journal · doi:10.1042/bj1790281 · Cited by 71
Chloroquine inhibits heme-dependent protein synthesis in Plasmodium falciparum.
Surolia, N., & Padmanaban, G. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.11.4786 · Cited by 70
Ginsburg, H., & Krugliak, M. (1992) · Biochemical Pharmacology · doi:10.1016/0006-2952(92)90662-3 · Cited by 61
Formation of haemozoin/β‐haematin under physiological conditions is not spontaneous
Pandey, A. V., & Tekwani, B. L. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00881-2 · Cited by 59
Non‐iron porphyrins inhibit β‐haematin (malaria pigment) polymerisation
Basilico, N., Monti, D., Olliaro, P., & Taramelli, D. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00533-4 · Cited by 56
Comprehensive organic chemistry The synthesis and reactions of organic compounds
(1979) · Comparative Biochemistry and Physiology Part B Comparative Biochemistry · doi:10.1016/0305-0491(79)90219-0 · Cited by 40
Cited by
Chemotherapy of schistosomiasis: present and future
Caffrey, C. R. (2007) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2007.05.031 · Cited by 277
Haemozoin: from melatonin pigment to drug target, diagnostic tool, and immune modulator
Hänscheid, T., Egan, T. J., & Grobusch, M. P. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70238-4 · Cited by 128
Self-citation
Metadata
- Authors
- Egan, T. J., Hunter, R., Kaschula, C. H., Marques, H. M., Misplon, A., & Walden, J.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 1999-12-31
- Volume
- 43
- Issue
- 2
- Pages
- 283-291
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2092358442
- Cited by
- 317
- References
- 20
- FWCI
- 3.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
